Market Highlights
- Overall vacancy stands at 27.3%, up 200 basis points (bps) year over year, driven by a 530 bps increase in direct vacancy to 20.5% from 15.2% in Q1 2025.
- VitriVax signed a 31,450 square foot (sf) lease at Flatiron Park in Boulder to expand its headquarters following a $17.3 millon Series B funding round to support growth and scale its vaccine technology platform.
- Ambrosia Biosciences raised $100.0 million in Series B funding to support early-stage clinical testing of its GLP-1 based therapy and continue developing additional treatments.